Provides that certain utilization review determinations shall be made consistent with medical and scientific evidence; includes services for mental health and substance use disorders as part of emergency services.
This bill revises New York’s insurance and public health laws governing utilization review, prior authorization, and medical necessity determinations for covered health care services. It requires health plans and utilization review agents to base coverage decisions on medical and scientific evidence, and it adds a statutory definition of “medical necessity” that focuses on whether a service addresses an insured’s specific health needs and is clinically appropriate in type, frequency, extent, site, and duration. The bill also directs reviewers to use peer-reviewed clinical criteria and, for mental health and substance use disorder coverage determinations, to rely on criteria designated or approved by the Office of Mental Health, with similar requirements in the Public Health Law for managed care enrollees.
The bill further limits retrospective claim review and audit practices. In the absence of fraud, a health plan may not reverse or alter a prior medical necessity determination through retrospective review, and may not downgrade or bundle claim coding if doing so would effectively undo that determination. It also requires utilization review agents to authorize requests for covered services or products that are medically necessary.
For emergency services, the bill expands the statutory treatment of emergency care to expressly include emergency services for mental health and substance use disorders provided by mobile crisis response teams or crisis receiving or stabilization centers. Such services would not be subject to prior authorization and could not be denied on retrospective review, except where the plan reasonably determines the services were never performed to stabilize or treat an emergency condition. The bill also updates utilization review rules for substance use disorder treatment, step therapy protocols, and mental health coverage to require peer-reviewed criteria that are consistent with medical and scientific evidence and publicly identify authors, reviewers, and editors.
The overall sentiment reflected in the bill text is consumer- and patient-protective, with a strong emphasis on limiting insurer discretion and strengthening access to mental health, substance use disorder, and emergency services. Because there are no committee transcripts or recorded votes provided, there is no direct evidence of debate or formal support/opposition in the available materials. Based on the bill’s structure, the likely policy goal is to reduce denials and retrospective reversals that conflict with clinical determinations.
The main points of potential contention are the bill’s restrictions on insurer audits and utilization review, which could be viewed by health plans as limiting cost-control tools and administrative flexibility. Another likely issue is the requirement that plans use designated or approved clinical review criteria for mental health and substance use disorder determinations, which may raise concerns about regulatory burden, implementation, and the scope of state oversight. Supporters would likely emphasize patient access, consistency in coverage decisions, and protections against inappropriate denials.
The bill would amend sections of the Insurance Law and Public Health Law to tighten standards for utilization review, prior authorization, retrospective review, and step therapy. It would create or revise statutory definitions of medical necessity, mental health and substance use disorders, and out-of-network referral denials, while requiring health plans and utilization review agents to use evidence-based, peer-reviewed clinical criteria and, in some cases, criteria approved by state mental health authorities. It would also expand emergency services protections to include certain behavioral health crisis services and restrict insurers from overturning prior necessity determinations through audits absent fraud.
No committee transcript or vote record is provided, so there is no documented floor or committee sentiment to summarize. The bill’s text suggests a generally supportive posture toward patients and providers, especially in behavioral health, by limiting insurer denials and requiring evidence-based review standards. The policy direction is clearly pro-access and anti-denial, which would likely draw support from patient advocates and behavioral health stakeholders, while insurers may view it less favorably.
The likely contention centers on the bill’s constraints on insurer utilization management. Health plans may object to the prohibition on retrospective reversal of medical necessity determinations, the limits on coding audits, and the requirement to use state-designated or approved clinical criteria for mental health and substance use disorder coverage decisions. Supporters would likely argue these provisions are necessary to prevent inappropriate denials and ensure that coverage decisions align with clinical evidence, particularly for emergency behavioral health services and step therapy overrides.